Come up with a name for your new list and we'll add to it:
Viracta Therapeutics raised a round of funding on July 13, 2010. Investors include
Latterell Venture Partners.
Viracta Therapeutics, formerly Hemaquest Pharmaceuticals, is a clinical-stage drug development company focused on advancing a proprietary viral activation therapy platform to address cancers associate…